Show PDB file:   
         Plain Text   HTML   (compressed file size)
QuickSearch:   
by PDB,NDB,UniProt,PROSITE Code or Search Term(s)  
(-)Asymmetric Unit
(-)Asym. Unit - sites
(-)Biological Unit 1
(-)Biol. Unit 1 - sites
(-)Biological Unit 2
(-)Biological Unit 3
(-)Biological Unit 4
(-)Biological Unit 5
collapse expand < >
Image Asymmetric Unit
Asymmetric Unit  (Jmol Viewer)
Image Asym. Unit - sites
Asym. Unit - sites  (Jmol Viewer)
Image Biological Unit 1
Biological Unit 1  (Jmol Viewer)
Image Biol. Unit 1 - sites
Biol. Unit 1 - sites  (Jmol Viewer)
Image Biological Unit 2
Biological Unit 2  (Jmol Viewer)
Image Biological Unit 3
Biological Unit 3  (Jmol Viewer)
Image Biological Unit 4
Biological Unit 4  (Jmol Viewer)
Image Biological Unit 5
Biological Unit 5  (Jmol Viewer)

(-) Description

Title :  CRYSTAL STRUCTURE OF TGFBRI COMPLEXED WITH A 2-AMINOIMIDAZOLE INHIBITOR
 
Authors :  P. A. Boriack-Sjodin, C. Fitch
Date :  16 Nov 08  (Deposition) - 27 Jan 09  (Release) - 10 Feb 09  (Revision)
Method :  X-RAY DIFFRACTION
Resolution :  3.35
Chains :  Asym. Unit :  A,B,C,D,E
Biol. Unit 1:  A  (1x)
Biol. Unit 2:  B  (1x)
Biol. Unit 3:  C  (1x)
Biol. Unit 4:  D  (1x)
Biol. Unit 5:  E  (1x)
Keywords :  Kinase, Tgfbeta, Structure-Based Drug Design, Protein- Inhibitor Complex, Atp-Binding, Craniosynostosis, Disease Mutation, Glycoprotein, Magnesium, Manganese, Membrane, Metal-Binding, Nucleotide-Binding, Phosphoprotein, Polymorphism, Receptor, Serine/Threonine-Protein Kinase, Transferase, Transmembrane (Keyword Search: [Gene Ontology, PubMed, Web (Google))
 
Reference :  D. Bonafoux, C. Chuaqui, P. A. Boriack-Sjodin, C. Fitch, G. Hankins, S. Josiah, C. Black, G. Hetu, L. Ling, W. C. Lee
2-Aminoimidazoles Inhibitors Of Tgf-Beta Receptor 1.
Bioorg. Med. Chem. Lett. V. 19 912 2009
PubMed-ID: 19135364  |  Reference-DOI: 10.1016/J.BMCL.2008.11.119
(for further references see the PDB file header)

(-) Compounds

Molecule 1 - TGF-BETA RECEPTOR TYPE-1
    Cell LineSF9
    ChainsA, B, C, D, E
    EC Number2.7.11.30
    EngineeredYES
    Expression SystemSPODOPTERA FRUGIPERDA
    Expression System Taxid7108
    Expression System VectorPBAC2
    Expression System Vector TypeBACULOVIRUS
    FragmentGS AND KINASE DOMAINS: UNP RESIDUES 162-503
    GeneTGFBR1
    Organism ScientificHOMO SAPIENS
    Organism Taxid9606
    SynonymTGF-BETA RECEPTOR TYPE I, TGFR-1, TGF-BETA TYPE I RECEPTOR, TRANSFORMING GROWTH FACTOR-BETA RECEPTOR TYPE I, TBETAR-I, SERINE/THREONINE-PROTEIN KINASE RECEPTOR R4, SKR4, ACTIVIN RECEPTOR-LIKE KINASE 5, ALK-5

 Structural Features

(-) Chains, Units

  12345
Asymmetric Unit ABCDE
Biological Unit 1 (1x)A    
Biological Unit 2 (1x) B   
Biological Unit 3 (1x)  C  
Biological Unit 4 (1x)   D 
Biological Unit 5 (1x)    E

Summary Information (see also Sequences/Alignments below)

(-) Ligands, Modified Residues, Ions  (2, 18)

Asymmetric Unit (2, 18)
No.NameCountTypeFull Name
155F5Ligand/IonN-[4-(5-FLUORO-6-METHYLPYRIDIN-2-YL)-5-QUINOXALIN-6-YL-1H-IMIDAZOL-2-YL]ACETAMIDE
2PO413Ligand/IonPHOSPHATE ION
Biological Unit 1 (2, 4)
No.NameCountTypeFull Name
155F1Ligand/IonN-[4-(5-FLUORO-6-METHYLPYRIDIN-2-YL)-5-QUINOXALIN-6-YL-1H-IMIDAZOL-2-YL]ACETAMIDE
2PO43Ligand/IonPHOSPHATE ION
Biological Unit 2 (2, 4)
No.NameCountTypeFull Name
155F1Ligand/IonN-[4-(5-FLUORO-6-METHYLPYRIDIN-2-YL)-5-QUINOXALIN-6-YL-1H-IMIDAZOL-2-YL]ACETAMIDE
2PO43Ligand/IonPHOSPHATE ION
Biological Unit 3 (2, 2)
No.NameCountTypeFull Name
155F1Ligand/IonN-[4-(5-FLUORO-6-METHYLPYRIDIN-2-YL)-5-QUINOXALIN-6-YL-1H-IMIDAZOL-2-YL]ACETAMIDE
2PO41Ligand/IonPHOSPHATE ION
Biological Unit 4 (2, 4)
No.NameCountTypeFull Name
155F1Ligand/IonN-[4-(5-FLUORO-6-METHYLPYRIDIN-2-YL)-5-QUINOXALIN-6-YL-1H-IMIDAZOL-2-YL]ACETAMIDE
2PO43Ligand/IonPHOSPHATE ION
Biological Unit 5 (2, 4)
No.NameCountTypeFull Name
155F1Ligand/IonN-[4-(5-FLUORO-6-METHYLPYRIDIN-2-YL)-5-QUINOXALIN-6-YL-1H-IMIDAZOL-2-YL]ACETAMIDE
2PO43Ligand/IonPHOSPHATE ION

(-) Sites  (18, 18)

Asymmetric Unit (18, 18)
No.NameEvidenceResiduesDescription
01AC1SOFTWAREILE A:211 , ALA A:230 , LYS A:232 , GLU A:245 , TYR A:249 , LEU A:278 , VAL A:279 , SER A:280 , ASP A:281 , TYR A:282 , HIS A:283 , ASN A:338 , LEU A:340 , ASP A:351BINDING SITE FOR RESIDUE 55F A 601
02AC2SOFTWAREILE B:211 , ALA B:230 , LYS B:232 , GLU B:245 , TYR B:249 , LEU B:278 , VAL B:279 , SER B:280 , TYR B:282 , HIS B:283 , ASN B:338 , LEU B:340 , ASP B:351BINDING SITE FOR RESIDUE 55F B 601
03AC3SOFTWAREILE C:211 , PHE C:216 , VAL C:219 , ALA C:230 , LYS C:232 , TYR C:249 , LEU C:260 , LEU C:278 , VAL C:279 , SER C:280 , TYR C:282 , HIS C:283 , LEU C:340 , ASP C:351BINDING SITE FOR RESIDUE 55F C 601
04AC4SOFTWAREILE D:211 , VAL D:219 , ALA D:230 , LYS D:232 , GLU D:245 , TYR D:249 , LEU D:260 , LEU D:278 , VAL D:279 , SER D:280 , TYR D:282 , HIS D:283 , ASN D:338 , LEU D:340 , ASP D:351BINDING SITE FOR RESIDUE 55F D 601
05AC5SOFTWAREILE E:211 , ALA E:230 , LYS E:232 , GLU E:245 , TYR E:249 , LEU E:260 , LEU E:278 , VAL E:279 , SER E:280 , TYR E:282 , HIS E:283 , ASN E:338 , LEU E:340 , ASP E:351BINDING SITE FOR RESIDUE 55F E 601
06AC6SOFTWAREHIS E:283 , LYS E:342 , LYS E:343BINDING SITE FOR RESIDUE PO4 E 1
07AC7SOFTWAREPO4 E:22 , ARG E:377 , LEU E:426 , ASP E:435BINDING SITE FOR RESIDUE PO4 E 2
08AC8SOFTWAREHIS B:283 , LYS B:342 , LYS B:343BINDING SITE FOR RESIDUE PO4 B 6
09AC9SOFTWARETYR A:282 , HIS A:283 , LYS A:342 , LYS A:343BINDING SITE FOR RESIDUE PO4 A 9
10BC1SOFTWAREHIS C:283 , LYS C:342 , LYS C:343BINDING SITE FOR RESIDUE PO4 C 10
11BC2SOFTWAREPO4 B:23 , LYS B:337 , ARG B:377 , SER B:434 , ASP B:435 , PRO B:436BINDING SITE FOR RESIDUE PO4 B 12
12BC3SOFTWAREHIS D:283 , LYS D:342 , LYS D:343BINDING SITE FOR RESIDUE PO4 D 13
13BC4SOFTWAREPO4 D:24 , ARG D:377 , LEU D:426 , ASP D:435 , PRO D:436BINDING SITE FOR RESIDUE PO4 D 14
14BC5SOFTWAREPO4 A:26 , ARG A:377 , LEU A:426 , ASP A:435 , PRO A:436BINDING SITE FOR RESIDUE PO4 A 21
15BC6SOFTWAREPO4 E:2 , LYS E:335 , LYS E:337 , THR E:375 , ARG E:377 , TYR E:378 , LEU E:426BINDING SITE FOR RESIDUE PO4 E 22
16BC7SOFTWAREPO4 B:12 , LYS B:335 , LYS B:337 , THR B:375 , LEU B:426BINDING SITE FOR RESIDUE PO4 B 23
17BC8SOFTWAREPO4 D:14 , LYS D:335 , LYS D:337 , THR D:375 , ARG D:377BINDING SITE FOR RESIDUE PO4 D 24
18BC9SOFTWAREPO4 A:21 , LYS A:335 , LYS A:337 , THR A:375 , LEU A:426BINDING SITE FOR RESIDUE PO4 A 26

(-) SS Bonds  (0, 0)

(no "SS Bond" information available for 3FAA)

(-) Cis Peptide Bonds  (0, 0)

(no "Cis Peptide Bond" information available for 3FAA)

 Sequence-Structure Mapping

(-) SAPs(SNPs)/Variants  (13, 65)

Asymmetric Unit (13, 65)
  dbSNPPDB
No.SourceVariant IDVariantUniProt IDStatusIDChainVariant
01UniProtVAR_022344T200ITGFR1_HUMANDisease (LDS1)121918712A/B/C/D/ET200I
02UniProtVAR_029481K232ETGFR1_HUMANDisease (LDS1)  ---A/B/C/D/EK232E
03UniProtVAR_029482S241LTGFR1_HUMANDisease (LDS1)111854391A/B/C/D/ES241L
04UniProtVAR_066720D266YTGFR1_HUMANDisease (LDS1)  ---A/B/C/D/ED266Y
05UniProtVAR_029483N267HTGFR1_HUMANUnclassified  ---A/B/C/D/EN267H
06UniProtVAR_041413Y291CTGFR1_HUMANPolymorphism35974499A/B/C/D/EY291C
07UniProtVAR_022345M318RTGFR1_HUMANDisease (LDS1)121918710A/B/C/D/EM318R
08UniProtVAR_066721D351GTGFR1_HUMANDisease (LDS1)  ---A/B/C/D/ED351G
09UniProtVAR_066722T375RTGFR1_HUMANDisease (LDS1)  ---A/B/C/D/ET375R
10UniProtVAR_022346D400GTGFR1_HUMANDisease (LDS1)121918711A/B/C/D/ED400G
11UniProtVAR_022347R487PTGFR1_HUMANDisease (LDS1)113605875A/B/C/D/ER487P
12UniProtVAR_029484R487QTGFR1_HUMANDisease (LDS1)113605875A/B/C/D/ER487Q
13UniProtVAR_029485R487WTGFR1_HUMANDisease (LDS1)111426349A/B/C/D/ER487W

  SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)
Biological Unit 1 (13, 13)
  dbSNPPDB
No.SourceVariant IDVariantUniProt IDStatusIDChainVariant
01UniProtVAR_022344T200ITGFR1_HUMANDisease (LDS1)121918712AT200I
02UniProtVAR_029481K232ETGFR1_HUMANDisease (LDS1)  ---AK232E
03UniProtVAR_029482S241LTGFR1_HUMANDisease (LDS1)111854391AS241L
04UniProtVAR_066720D266YTGFR1_HUMANDisease (LDS1)  ---AD266Y
05UniProtVAR_029483N267HTGFR1_HUMANUnclassified  ---AN267H
06UniProtVAR_041413Y291CTGFR1_HUMANPolymorphism35974499AY291C
07UniProtVAR_022345M318RTGFR1_HUMANDisease (LDS1)121918710AM318R
08UniProtVAR_066721D351GTGFR1_HUMANDisease (LDS1)  ---AD351G
09UniProtVAR_066722T375RTGFR1_HUMANDisease (LDS1)  ---AT375R
10UniProtVAR_022346D400GTGFR1_HUMANDisease (LDS1)121918711AD400G
11UniProtVAR_022347R487PTGFR1_HUMANDisease (LDS1)113605875AR487P
12UniProtVAR_029484R487QTGFR1_HUMANDisease (LDS1)113605875AR487Q
13UniProtVAR_029485R487WTGFR1_HUMANDisease (LDS1)111426349AR487W

  SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)
Biological Unit 2 (13, 13)
  dbSNPPDB
No.SourceVariant IDVariantUniProt IDStatusIDChainVariant
01UniProtVAR_022344T200ITGFR1_HUMANDisease (LDS1)121918712BT200I
02UniProtVAR_029481K232ETGFR1_HUMANDisease (LDS1)  ---BK232E
03UniProtVAR_029482S241LTGFR1_HUMANDisease (LDS1)111854391BS241L
04UniProtVAR_066720D266YTGFR1_HUMANDisease (LDS1)  ---BD266Y
05UniProtVAR_029483N267HTGFR1_HUMANUnclassified  ---BN267H
06UniProtVAR_041413Y291CTGFR1_HUMANPolymorphism35974499BY291C
07UniProtVAR_022345M318RTGFR1_HUMANDisease (LDS1)121918710BM318R
08UniProtVAR_066721D351GTGFR1_HUMANDisease (LDS1)  ---BD351G
09UniProtVAR_066722T375RTGFR1_HUMANDisease (LDS1)  ---BT375R
10UniProtVAR_022346D400GTGFR1_HUMANDisease (LDS1)121918711BD400G
11UniProtVAR_022347R487PTGFR1_HUMANDisease (LDS1)113605875BR487P
12UniProtVAR_029484R487QTGFR1_HUMANDisease (LDS1)113605875BR487Q
13UniProtVAR_029485R487WTGFR1_HUMANDisease (LDS1)111426349BR487W

  SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)
Biological Unit 3 (13, 13)
  dbSNPPDB
No.SourceVariant IDVariantUniProt IDStatusIDChainVariant
01UniProtVAR_022344T200ITGFR1_HUMANDisease (LDS1)121918712CT200I
02UniProtVAR_029481K232ETGFR1_HUMANDisease (LDS1)  ---CK232E
03UniProtVAR_029482S241LTGFR1_HUMANDisease (LDS1)111854391CS241L
04UniProtVAR_066720D266YTGFR1_HUMANDisease (LDS1)  ---CD266Y
05UniProtVAR_029483N267HTGFR1_HUMANUnclassified  ---CN267H
06UniProtVAR_041413Y291CTGFR1_HUMANPolymorphism35974499CY291C
07UniProtVAR_022345M318RTGFR1_HUMANDisease (LDS1)121918710CM318R
08UniProtVAR_066721D351GTGFR1_HUMANDisease (LDS1)  ---CD351G
09UniProtVAR_066722T375RTGFR1_HUMANDisease (LDS1)  ---CT375R
10UniProtVAR_022346D400GTGFR1_HUMANDisease (LDS1)121918711CD400G
11UniProtVAR_022347R487PTGFR1_HUMANDisease (LDS1)113605875CR487P
12UniProtVAR_029484R487QTGFR1_HUMANDisease (LDS1)113605875CR487Q
13UniProtVAR_029485R487WTGFR1_HUMANDisease (LDS1)111426349CR487W

  SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)
Biological Unit 4 (13, 13)
  dbSNPPDB
No.SourceVariant IDVariantUniProt IDStatusIDChainVariant
01UniProtVAR_022344T200ITGFR1_HUMANDisease (LDS1)121918712DT200I
02UniProtVAR_029481K232ETGFR1_HUMANDisease (LDS1)  ---DK232E
03UniProtVAR_029482S241LTGFR1_HUMANDisease (LDS1)111854391DS241L
04UniProtVAR_066720D266YTGFR1_HUMANDisease (LDS1)  ---DD266Y
05UniProtVAR_029483N267HTGFR1_HUMANUnclassified  ---DN267H
06UniProtVAR_041413Y291CTGFR1_HUMANPolymorphism35974499DY291C
07UniProtVAR_022345M318RTGFR1_HUMANDisease (LDS1)121918710DM318R
08UniProtVAR_066721D351GTGFR1_HUMANDisease (LDS1)  ---DD351G
09UniProtVAR_066722T375RTGFR1_HUMANDisease (LDS1)  ---DT375R
10UniProtVAR_022346D400GTGFR1_HUMANDisease (LDS1)121918711DD400G
11UniProtVAR_022347R487PTGFR1_HUMANDisease (LDS1)113605875DR487P
12UniProtVAR_029484R487QTGFR1_HUMANDisease (LDS1)113605875DR487Q
13UniProtVAR_029485R487WTGFR1_HUMANDisease (LDS1)111426349DR487W

  SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)
Biological Unit 5 (13, 13)
  dbSNPPDB
No.SourceVariant IDVariantUniProt IDStatusIDChainVariant
01UniProtVAR_022344T200ITGFR1_HUMANDisease (LDS1)121918712ET200I
02UniProtVAR_029481K232ETGFR1_HUMANDisease (LDS1)  ---EK232E
03UniProtVAR_029482S241LTGFR1_HUMANDisease (LDS1)111854391ES241L
04UniProtVAR_066720D266YTGFR1_HUMANDisease (LDS1)  ---ED266Y
05UniProtVAR_029483N267HTGFR1_HUMANUnclassified  ---EN267H
06UniProtVAR_041413Y291CTGFR1_HUMANPolymorphism35974499EY291C
07UniProtVAR_022345M318RTGFR1_HUMANDisease (LDS1)121918710EM318R
08UniProtVAR_066721D351GTGFR1_HUMANDisease (LDS1)  ---ED351G
09UniProtVAR_066722T375RTGFR1_HUMANDisease (LDS1)  ---ET375R
10UniProtVAR_022346D400GTGFR1_HUMANDisease (LDS1)121918711ED400G
11UniProtVAR_022347R487PTGFR1_HUMANDisease (LDS1)113605875ER487P
12UniProtVAR_029484R487QTGFR1_HUMANDisease (LDS1)113605875ER487Q
13UniProtVAR_029485R487WTGFR1_HUMANDisease (LDS1)111426349ER487W

  SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)

(-) PROSITE Motifs  (3, 15)

Asymmetric Unit (3, 15)
 PROSITEUniProtKBPDB
No.IDACDescriptionIDLocationCountLocation
1GSPS51256 GS domain profile.TGFR1_HUMAN175-204
 
 
 
 
  5A:175-204
B:175-204
C:175-204
D:175-204
E:175-204
2PROTEIN_KINASE_ATPPS00107 Protein kinases ATP-binding region signature.TGFR1_HUMAN211-232
 
 
 
 
  5A:211-232
B:211-232
C:211-232
D:211-232
E:211-232
3PROTEIN_KINASE_STPS00108 Serine/Threonine protein kinases active-site signature.TGFR1_HUMAN329-341
 
 
 
 
  5A:329-341
B:329-341
C:329-341
D:329-341
E:329-341
Biological Unit 1 (3, 3)
 PROSITEUniProtKBPDB
No.IDACDescriptionIDLocationCountLocation
1GSPS51256 GS domain profile.TGFR1_HUMAN175-204
 
 
 
 
  1A:175-204
-
-
-
-
2PROTEIN_KINASE_ATPPS00107 Protein kinases ATP-binding region signature.TGFR1_HUMAN211-232
 
 
 
 
  1A:211-232
-
-
-
-
3PROTEIN_KINASE_STPS00108 Serine/Threonine protein kinases active-site signature.TGFR1_HUMAN329-341
 
 
 
 
  1A:329-341
-
-
-
-
Biological Unit 2 (3, 3)
 PROSITEUniProtKBPDB
No.IDACDescriptionIDLocationCountLocation
1GSPS51256 GS domain profile.TGFR1_HUMAN175-204
 
 
 
 
  1-
B:175-204
-
-
-
2PROTEIN_KINASE_ATPPS00107 Protein kinases ATP-binding region signature.TGFR1_HUMAN211-232
 
 
 
 
  1-
B:211-232
-
-
-
3PROTEIN_KINASE_STPS00108 Serine/Threonine protein kinases active-site signature.TGFR1_HUMAN329-341
 
 
 
 
  1-
B:329-341
-
-
-
Biological Unit 3 (3, 3)
 PROSITEUniProtKBPDB
No.IDACDescriptionIDLocationCountLocation
1GSPS51256 GS domain profile.TGFR1_HUMAN175-204
 
 
 
 
  1-
-
C:175-204
-
-
2PROTEIN_KINASE_ATPPS00107 Protein kinases ATP-binding region signature.TGFR1_HUMAN211-232
 
 
 
 
  1-
-
C:211-232
-
-
3PROTEIN_KINASE_STPS00108 Serine/Threonine protein kinases active-site signature.TGFR1_HUMAN329-341
 
 
 
 
  1-
-
C:329-341
-
-
Biological Unit 4 (3, 3)
 PROSITEUniProtKBPDB
No.IDACDescriptionIDLocationCountLocation
1GSPS51256 GS domain profile.TGFR1_HUMAN175-204
 
 
 
 
  1-
-
-
D:175-204
-
2PROTEIN_KINASE_ATPPS00107 Protein kinases ATP-binding region signature.TGFR1_HUMAN211-232
 
 
 
 
  1-
-
-
D:211-232
-
3PROTEIN_KINASE_STPS00108 Serine/Threonine protein kinases active-site signature.TGFR1_HUMAN329-341
 
 
 
 
  1-
-
-
D:329-341
-
Biological Unit 5 (3, 3)
 PROSITEUniProtKBPDB
No.IDACDescriptionIDLocationCountLocation
1GSPS51256 GS domain profile.TGFR1_HUMAN175-204
 
 
 
 
  1-
-
-
-
E:175-204
2PROTEIN_KINASE_ATPPS00107 Protein kinases ATP-binding region signature.TGFR1_HUMAN211-232
 
 
 
 
  1-
-
-
-
E:211-232
3PROTEIN_KINASE_STPS00108 Serine/Threonine protein kinases active-site signature.TGFR1_HUMAN329-341
 
 
 
 
  1-
-
-
-
E:329-341

(-) Exons   (7, 35)

Asymmetric Unit (7, 35)
 ENSEMBLUniProtKBPDB
No.Transcript IDExonExon IDGenome LocationLengthIDLocationLengthCountLocationLength
1.1ENST000003749941ENSE00001090681chr9:101867412-101867584173TGFR1_HUMAN1-33330--
1.2ENST000003749942ENSE00001149190chr9:101891137-101891382246TGFR1_HUMAN33-115830--
1.3ENST000003749943ENSE00001149139chr9:101894791-101895021231TGFR1_HUMAN115-192785A:171-192
B:171-192
C:171-192
D:171-192
E:171-192
22
22
22
22
22
1.4ENST000003749944ENSE00001090680chr9:101900141-101900371231TGFR1_HUMAN192-269785A:192-269
B:192-269
C:192-269
D:192-269
E:192-269
78
78
78
78
78
1.5ENST000003749945ENSE00001643263chr9:101904818-101904985168TGFR1_HUMAN269-325575A:269-325
B:269-325 (gaps)
C:269-325
D:269-325
E:269-325
57
57
57
57
57
1.6ENST000003749946ENSE00000926563chr9:101907014-101907170157TGFR1_HUMAN325-377535A:325-377 (gaps)
B:325-377 (gaps)
C:325-377
D:325-377
E:325-377
53
53
53
53
53
1.7ENST000003749947ENSE00000926564chr9:101908767-101908891125TGFR1_HUMAN377-419435A:377-419
B:377-419
C:377-419
D:377-419
E:377-419
43
43
43
43
43
1.8ENST000003749948ENSE00000926565chr9:101909936-101910066131TGFR1_HUMAN419-462445A:419-462
B:419-462
C:419-462
D:419-462
E:419-462
44
44
44
44
44
1.9bENST000003749949bENSE00001822848chr9:101911462-1019165855124TGFR1_HUMAN463-503415A:463-500
B:463-501
C:463-500
D:463-500
E:463-500
38
39
38
38
38

(-) Sequences/Alignments

Asymmetric Unit
   Reformat: Number of residues per line =  ('0' or empty: single-line sequence representation)
  Number of residues per labelling interval =   
  UniProt sequence: complete  aligned part    
   Show mapping: SCOP domains CATH domains Pfam domains Secondary structure (by author)
SAPs(SNPs) PROSITE motifs Exons
(details for a mapped element are shown in a popup box when the mouse pointer rests over it)
Chain A from PDB  Type:PROTEIN  Length:328
 aligned with TGFR1_HUMAN | P36897 from UniProtKB/Swiss-Prot  Length:503

    Alignment length:330
                                   180       190       200       210       220       230       240       250       260       270       280       290       300       310       320       330       340       350       360       370       380       390       400       410       420       430       440       450       460       470       480       490       500
          TGFR1_HUMAN   171 ISEGTTLKDLIYDMTTSGSGSGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG 500
               SCOP domains ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ SCOP domains
               CATH domains 3faaA01 A:171-284 Phosphorylase Kinase; domain 1                                                                  3faaA02 A:285-500 Transferase(Phosphotransferase) domain 1                                                                                                                                                               CATH domains
               Pfam domains ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ Pfam domains
         Sec.struct. author .....hhhhhhhhhhh.......hhhhhhhhhh..eeeeeeee...eeeeeeee..eeeeeeeee..hhhhhhhhhhhh..............eeee..hhhh.eeeeee......hhhhhhhhh..hhhhhhhhhhhhhhhhhhhhh.........eee........eee.....eee.hhhhheeee....ee..--..........hhhhhh.......hhhhhhhhhhhhhhhhhhhhh.......................hhhhhhhhhh........hhhhh.hhhhhhhhhhhhhhh........hhhhhhhhhhhhhhhh. Sec.struct. author
             SAPs(SNPs) (1) -----------------------------I-------------------------------E--------L------------------------YH-----------------------C--------------------------R--------------------------------G-----------------------R------------------------G--------------------------------------------------------------------------------------P------------- SAPs(SNPs) (1)
             SAPs(SNPs) (2) ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------Q------------- SAPs(SNPs) (2)
             SAPs(SNPs) (3) ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------W------------- SAPs(SNPs) (3)
                    PROSITE ----GS  PDB: A:175-204            ------PROTEIN_KINASE_ATP    ------------------------------------------------------------------------------------------------PROTEIN_KINAS--------------------------------------------------------------------------------------------------------------------------------------------------------------- PROSITE
           Transcript 1 (1) Exon 1.3 [INCOMPLETE] ----------------------------------------------------------------------------Exon 1.5  PDB: A:269-325 UniProt: 269-325                ---------------------------------------------------Exon 1.7  PDB: A:377-419 UniProt: 377-419  -------------------------------------------Exon 1.9b  PDB: A:463-500 [INCOMPLETE] Transcript 1 (1)
           Transcript 1 (2) ---------------------Exon 1.4  PDB: A:192-269 UniProt: 192-269                                     -------------------------------------------------------Exon 1.6  PDB: A:325-377 (gaps) UniProt: 325-377     -----------------------------------------Exon 1.8  PDB: A:419-462 UniProt: 419-462   -------------------------------------- Transcript 1 (2)
                 3faa A 171 ISEGTTLKDLIYDMTTSGSGSGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDI--NHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG 500
                                   180       190       200       210       220       230       240       250       260       270       280       290       300       310       320       330       340       350       360      |370       380       390       400       410       420       430       440       450       460       470       480       490       500
                                                                                                                                                                                                                              367  |                                                                                                                                  
                                                                                                                                                                                                                                 370                                                                                                                                  

Chain B from PDB  Type:PROTEIN  Length:324
 aligned with TGFR1_HUMAN | P36897 from UniProtKB/Swiss-Prot  Length:503

    Alignment length:331
                                   180       190       200       210       220       230       240       250       260       270       280       290       300       310       320       330       340       350       360       370       380       390       400       410       420       430       440       450       460       470       480       490       500 
          TGFR1_HUMAN   171 ISEGTTLKDLIYDMTTSGSGSGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGI 501
               SCOP domains ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- SCOP domains
               CATH domains 3faaB01 B:171-284 Phosphorylase Kinase; domain 1                                                                  3faaB02 B:285-501 Transferase(Phosph    otransferase) domain 1                                                                                                                                                            CATH domains
               Pfam domains ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Pfam domains
         Sec.struct. author .....hhhhhhhhhhhh......hhhhhhhhhhh.eeeeeeee...eeeeeeee..eeeeeeee...hhhhhhhhhhhhh...........eeeeee..hhhhh.eeeee......hhhhhhhhh..hhhhhhhhhhhhhhhhhhhhh..----...eee....hhh.eee.....eee.hhhhheeee....ee..---....hhhhhhhhhhh......hhhhhhhhhhhhhhhhhhhhhh.......................hhhhhhhhhh.........hhhhhhhhhhhhhhhhhhhhh.hhhhh.hhhhhhhhhhhhhhhh.. Sec.struct. author
             SAPs(SNPs) (1) -----------------------------I-------------------------------E--------L------------------------YH-----------------------C--------------------------R--------------------------------G-----------------------R------------------------G--------------------------------------------------------------------------------------P-------------- SAPs(SNPs) (1)
             SAPs(SNPs) (2) ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------Q-------------- SAPs(SNPs) (2)
             SAPs(SNPs) (3) ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------W-------------- SAPs(SNPs) (3)
                    PROSITE ----GS  PDB: B:175-204            ------PROTEIN_KINASE_ATP    ------------------------------------------------------------------------------------------------PROTEIN_KINAS---------------------------------------------------------------------------------------------------------------------------------------------------------------- PROSITE
           Transcript 1 (1) Exon 1.3 [INCOMPLETE] ----------------------------------------------------------------------------Exon 1.5  PDB: B:269-325 (gaps) UniProt: 269-325         ---------------------------------------------------Exon 1.7  PDB: B:377-419 UniProt: 377-419  -------------------------------------------Exon 1.9b  PDB: B:463-501 [INCOMPLETE]  Transcript 1 (1)
           Transcript 1 (2) ---------------------Exon 1.4  PDB: B:192-269 UniProt: 192-269                                     -------------------------------------------------------Exon 1.6  PDB: B:325-377 (gaps) UniProt: 325-377     -----------------------------------------Exon 1.8  PDB: B:419-462 UniProt: 419-462   --------------------------------------- Transcript 1 (2)
                 3faa B 171 ISEGTTLKDLIYDMTTSGSGSGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEI----GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDI---HRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGI 501
                                   180       190       200       210       220       230       240       250       260       270       280       290       300       310       320    |  330       340       350       360      |  -|      380       390       400       410       420       430       440       450       460       470       480       490       500 
                                                                                                                                                                               320  325                                       367 371                                                                                                                                  

Chain C from PDB  Type:PROTEIN  Length:330
 aligned with TGFR1_HUMAN | P36897 from UniProtKB/Swiss-Prot  Length:503

    Alignment length:330
                                   180       190       200       210       220       230       240       250       260       270       280       290       300       310       320       330       340       350       360       370       380       390       400       410       420       430       440       450       460       470       480       490       500
          TGFR1_HUMAN   171 ISEGTTLKDLIYDMTTSGSGSGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG 500
               SCOP domains ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ SCOP domains
               CATH domains 3faaC01 C:171-284 Phosphorylase Kinase; domain 1                                                                  3faaC02 C:285-500 Transferase(Phosphotransferase) domain 1                                                                                                                                                               CATH domains
               Pfam domains ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ Pfam domains
         Sec.struct. author .....hhhhhhhhhh........hhhhhhhhhh..eeeeeeee....eeeeeee..eeeeeeeehhhhhhhhhhhhhhh............eeeeee........eeeeee....eehhhhh.......hhhhhhhhhhhhhhhhhhh.........eee........eee.....eee......eeee....ee.........hhhhhhhhhhh.......hhhhhhhhhhhhhhhhhhhhh........................hhhhhhhhhh........hhhhhhhhhhhhhhhhhh....hhhhh.hhhhhhhhhhhhhh... Sec.struct. author
             SAPs(SNPs) (1) -----------------------------I-------------------------------E--------L------------------------YH-----------------------C--------------------------R--------------------------------G-----------------------R------------------------G--------------------------------------------------------------------------------------P------------- SAPs(SNPs) (1)
             SAPs(SNPs) (2) ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------Q------------- SAPs(SNPs) (2)
             SAPs(SNPs) (3) ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------W------------- SAPs(SNPs) (3)
                    PROSITE ----GS  PDB: C:175-204            ------PROTEIN_KINASE_ATP    ------------------------------------------------------------------------------------------------PROTEIN_KINAS--------------------------------------------------------------------------------------------------------------------------------------------------------------- PROSITE
           Transcript 1 (1) Exon 1.3 [INCOMPLETE] ----------------------------------------------------------------------------Exon 1.5  PDB: C:269-325 UniProt: 269-325                ---------------------------------------------------Exon 1.7  PDB: C:377-419 UniProt: 377-419  -------------------------------------------Exon 1.9b  PDB: C:463-500 [INCOMPLETE] Transcript 1 (1)
           Transcript 1 (2) ---------------------Exon 1.4  PDB: C:192-269 UniProt: 192-269                                     -------------------------------------------------------Exon 1.6  PDB: C:325-377 UniProt: 325-377            -----------------------------------------Exon 1.8  PDB: C:419-462 UniProt: 419-462   -------------------------------------- Transcript 1 (2)
                 3faa C 171 ISEGTTLKDLIYDMTTSGSGSGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG 500
                                   180       190       200       210       220       230       240       250       260       270       280       290       300       310       320       330       340       350       360       370       380       390       400       410       420       430       440       450       460       470       480       490       500

Chain D from PDB  Type:PROTEIN  Length:330
 aligned with TGFR1_HUMAN | P36897 from UniProtKB/Swiss-Prot  Length:503

    Alignment length:330
                                   180       190       200       210       220       230       240       250       260       270       280       290       300       310       320       330       340       350       360       370       380       390       400       410       420       430       440       450       460       470       480       490       500
          TGFR1_HUMAN   171 ISEGTTLKDLIYDMTTSGSGSGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG 500
               SCOP domains ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ SCOP domains
               CATH domains 3faaD01 D:171-284 Phosphorylase Kinase; domain 1                                                                  3faaD02 D:285-500 Transferase(Phosphotransferase) domain 1                                                                                                                                                               CATH domains
               Pfam domains ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ Pfam domains
         Sec.struct. author .....hhhhhhhhhhh.......hhhhhhhhhhhheeeeeeee...eeeeeeee..eeeeeeee...hhhhhhhhhhhhh...........eeeee...hhhhh.eeeeee.....hhhhhhhh...hhhhhhhhhhhhhhhhhhhhh.........eee....hhh.eee.....eee......eeee....ee.........hhhhhhhhhhh.......hhhhhhhhhhhhhhhhhhhhh.......................hhhhhhhhh...............hhhhhhhhhhhhhhhh.hhhhh.hhhhhhhhhhhhhh... Sec.struct. author
             SAPs(SNPs) (1) -----------------------------I-------------------------------E--------L------------------------YH-----------------------C--------------------------R--------------------------------G-----------------------R------------------------G--------------------------------------------------------------------------------------P------------- SAPs(SNPs) (1)
             SAPs(SNPs) (2) ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------Q------------- SAPs(SNPs) (2)
             SAPs(SNPs) (3) ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------W------------- SAPs(SNPs) (3)
                    PROSITE ----GS  PDB: D:175-204            ------PROTEIN_KINASE_ATP    ------------------------------------------------------------------------------------------------PROTEIN_KINAS--------------------------------------------------------------------------------------------------------------------------------------------------------------- PROSITE
           Transcript 1 (1) Exon 1.3 [INCOMPLETE] ----------------------------------------------------------------------------Exon 1.5  PDB: D:269-325 UniProt: 269-325                ---------------------------------------------------Exon 1.7  PDB: D:377-419 UniProt: 377-419  -------------------------------------------Exon 1.9b  PDB: D:463-500 [INCOMPLETE] Transcript 1 (1)
           Transcript 1 (2) ---------------------Exon 1.4  PDB: D:192-269 UniProt: 192-269                                     -------------------------------------------------------Exon 1.6  PDB: D:325-377 UniProt: 325-377            -----------------------------------------Exon 1.8  PDB: D:419-462 UniProt: 419-462   -------------------------------------- Transcript 1 (2)
                 3faa D 171 ISEGTTLKDLIYDMTTSGSGSGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG 500
                                   180       190       200       210       220       230       240       250       260       270       280       290       300       310       320       330       340       350       360       370       380       390       400       410       420       430       440       450       460       470       480       490       500

Chain E from PDB  Type:PROTEIN  Length:330
 aligned with TGFR1_HUMAN | P36897 from UniProtKB/Swiss-Prot  Length:503

    Alignment length:330
                                   180       190       200       210       220       230       240       250       260       270       280       290       300       310       320       330       340       350       360       370       380       390       400       410       420       430       440       450       460       470       480       490       500
          TGFR1_HUMAN   171 ISEGTTLKDLIYDMTTSGSGSGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG 500
               SCOP domains ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ SCOP domains
               CATH domains 3faaE01 E:171-284 Phosphorylase Kinase; domain 1                                                                  3faaE02 E:285-500 Transferase(Phosphotransferase) domain 1                                                                                                                                                               CATH domains
               Pfam domains ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ Pfam domains
         Sec.struct. author .....hhhhhhhhhhhh......hhhhhhhhhhhhee....ee...eeeeeeee..eeeeeeee...hhhhhhhhhhhh............eeeee...hhhhh.eeeee......hhhhhhhhh..hhhhhhhhhhhhhhhhhhhhh.........eee....hhh.eee.....eee......eeee....eee.............hhhhhh.......hhhhhhhhhhhhhhhhhhhhhh......................hhhhhhhhhhh.............hhhhhhhhhhhhh..........hhhhhhhhhhhhhhh.. Sec.struct. author
             SAPs(SNPs) (1) -----------------------------I-------------------------------E--------L------------------------YH-----------------------C--------------------------R--------------------------------G-----------------------R------------------------G--------------------------------------------------------------------------------------P------------- SAPs(SNPs) (1)
             SAPs(SNPs) (2) ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------Q------------- SAPs(SNPs) (2)
             SAPs(SNPs) (3) ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------W------------- SAPs(SNPs) (3)
                    PROSITE ----GS  PDB: E:175-204            ------PROTEIN_KINASE_ATP    ------------------------------------------------------------------------------------------------PROTEIN_KINAS--------------------------------------------------------------------------------------------------------------------------------------------------------------- PROSITE
           Transcript 1 (1) Exon 1.3 [INCOMPLETE] ----------------------------------------------------------------------------Exon 1.5  PDB: E:269-325 UniProt: 269-325                ---------------------------------------------------Exon 1.7  PDB: E:377-419 UniProt: 377-419  -------------------------------------------Exon 1.9b  PDB: E:463-500 [INCOMPLETE] Transcript 1 (1)
           Transcript 1 (2) ---------------------Exon 1.4  PDB: E:192-269 UniProt: 192-269                                     -------------------------------------------------------Exon 1.6  PDB: E:325-377 UniProt: 325-377            -----------------------------------------Exon 1.8  PDB: E:419-462 UniProt: 419-462   -------------------------------------- Transcript 1 (2)
                 3faa E 171 ISEGTTLKDLIYDMTTSGSGSGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG 500
                                   180       190       200       210       220       230       240       250       260       270       280       290       300       310       320       330       340       350       360       370       380       390       400       410       420       430       440       450       460       470       480       490       500

   Legend:   → Mismatch (orange background)
  - → Gap (green background, '-', border residues have a numbering label)
    → Modified Residue (blue background, lower-case, 'x' indicates undefined single-letter code, labelled with number + name)
  x → Chemical Group (purple background, 'x', labelled with number + name, e.g. ACE or NH2)
  extra numbering lines below/above indicate numbering irregularities and modified residue names etc., number ends below/above '|'

 Classification and Annotation

(-) SCOP Domains  (0, 0)

(no "SCOP Domain" information available for 3FAA)

(-) CATH Domains  (2, 10)

Asymmetric Unit
(-)
Class: Alpha Beta (26913)

(-) Pfam Domains  (0, 0)

(no "Pfam Domain" information available for 3FAA)

(-) Gene Ontology  (99, 99)

Asymmetric Unit(hide GO term definitions)
Chain A,B,C,D,E   (TGFR1_HUMAN | P36897)
molecular function
    GO:0005524    ATP binding    Interacting selectively and non-covalently with ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator.
    GO:0070411    I-SMAD binding    Interacting selectively and non-covalently with an inhibitory SMAD signaling protein.
    GO:0046332    SMAD binding    Interacting selectively and non-covalently with a SMAD signaling protein.
    GO:0019838    growth factor binding    Interacting selectively and non-covalently with any growth factor, proteins or polypeptides that stimulate a cell or organism to grow or proliferate.
    GO:0016301    kinase activity    Catalysis of the transfer of a phosphate group, usually from ATP, to a substrate molecule.
    GO:0046872    metal ion binding    Interacting selectively and non-covalently with any metal ion.
    GO:0000166    nucleotide binding    Interacting selectively and non-covalently with a nucleotide, any compound consisting of a nucleoside that is esterified with (ortho)phosphate or an oligophosphate at any hydroxyl group on the ribose or deoxyribose.
    GO:0005515    protein binding    Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
    GO:0004672    protein kinase activity    Catalysis of the phosphorylation of an amino acid residue in a protein, usually according to the reaction: a protein + ATP = a phosphoprotein + ADP.
    GO:0004674    protein serine/threonine kinase activity    Catalysis of the reactions: ATP + protein serine = ADP + protein serine phosphate, and ATP + protein threonine = ADP + protein threonine phosphate.
    GO:0005102    receptor binding    Interacting selectively and non-covalently with one or more specific sites on a receptor molecule, a macromolecule that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function.
    GO:0005057    signal transducer activity, downstream of receptor    Conveys a signal from an upstream receptor or intracellular signal transducer, converting the signal into a form where it can ultimately trigger a change in the state or activity of a cell.
    GO:0004702    signal transducer, downstream of receptor, with serine/threonine kinase activity    Conveys a signal from an upstream receptor or intracellular signal transducer by catalysis of the reaction: ATP protein serine = ADP + protein serine phosphate, and ATP + protein threonine = ADP + protein threonine phosphate.
    GO:0016740    transferase activity    Catalysis of the transfer of a group, e.g. a methyl group, glycosyl group, acyl group, phosphorus-containing, or other groups, from one compound (generally regarded as the donor) to another compound (generally regarded as the acceptor). Transferase is the systematic name for any enzyme of EC class 2.
    GO:0050431    transforming growth factor beta binding    Interacting selectively and non-covalently with TGF-beta, transforming growth factor beta, a multifunctional peptide that controls proliferation, differentiation and other functions in many cell types.
    GO:0005025    transforming growth factor beta receptor activity, type I    Combining with a complex of transforming growth factor beta and a type II TGF-beta receptor to initiate a change in cell activity; upon binding, acts as a downstream transducer of TGF-beta signals.
    GO:0005024    transforming growth factor beta-activated receptor activity    Combining with a transforming growth factor beta (TGFbeta) and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity by catalysis of the reaction: ATP protein serine = ADP + protein serine phosphate, and ATP + protein threonine = ADP + protein threonine phosphate.
    GO:0004675    transmembrane receptor protein serine/threonine kinase activity    Combining with a signal and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity by catalysis of the reaction: ATP protein serine = ADP + protein serine phosphate, and ATP + protein threonine = ADP + protein threonine phosphate.
    GO:0005114    type II transforming growth factor beta receptor binding    Interacting selectively and non-covalently with a type II transforming growth factor beta receptor.
biological process
    GO:0000186    activation of MAPKK activity    The initiation of the activity of the inactive enzyme MAP kinase kinase (MAPKK).
    GO:0032924    activin receptor signaling pathway    A series of molecular signals initiated by the binding of an extracellular ligand to an activin receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription.
    GO:0001525    angiogenesis    Blood vessel formation when new vessels emerge from the proliferation of pre-existing blood vessels.
    GO:0009952    anterior/posterior pattern specification    The regionalization process in which specific areas of cell differentiation are determined along the anterior-posterior axis. The anterior-posterior axis is defined by a line that runs from the head or mouth of an organism to the tail or opposite end of the organism.
    GO:0006915    apoptotic process    A programmed cell death process which begins when a cell receives an internal (e.g. DNA damage) or external signal (e.g. an extracellular death ligand), and proceeds through a series of biochemical events (signaling pathway phase) which trigger an execution phase. The execution phase is the last step of an apoptotic process, and is typically characterized by rounding-up of the cell, retraction of pseudopodes, reduction of cellular volume (pyknosis), chromatin condensation, nuclear fragmentation (karyorrhexis), plasma membrane blebbing and fragmentation of the cell into apoptotic bodies. When the execution phase is completed, the cell has died.
    GO:0048844    artery morphogenesis    The process in which the anatomical structures of arterial blood vessels are generated and organized. Arteries are blood vessels that transport blood from the heart to the body and its organs.
    GO:0001824    blastocyst development    The process whose specific outcome is the progression of the blastocyst over time, from its formation to the mature structure. The mammalian blastocyst is a hollow ball of cells containing two cell types, the inner cell mass and the trophectoderm.
    GO:0060317    cardiac epithelial to mesenchymal transition    A transition where a cardiac epithelial cell loses apical/basolateral polarity, severs intercellular adhesive junctions, degrades basement membrane components and becomes a migratory mesenchymal cell.
    GO:0007050    cell cycle arrest    A regulatory process that halts progression through the cell cycle during one of the normal phases (G1, S, G2, M).
    GO:0030154    cell differentiation    The process in which relatively unspecialized cells, e.g. embryonic or regenerative cells, acquire specialized structural and/or functional features that characterize the cells, tissues, or organs of the mature organism or some other relatively stable phase of the organism's life history. Differentiation includes the processes involved in commitment of a cell to a specific fate and its subsequent development to the mature state.
    GO:0048870    cell motility    Any process involved in the controlled self-propelled movement of a cell that results in translocation of the cell from one place to another.
    GO:0071560    cellular response to transforming growth factor beta stimulus    Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a transforming growth factor beta stimulus.
    GO:0030199    collagen fibril organization    Any process that determines the size and arrangement of collagen fibrils within an extracellular matrix.
    GO:0048701    embryonic cranial skeleton morphogenesis    The process in which the anatomical structures of the cranial skeleton are generated and organized during the embryonic phase.
    GO:0042118    endothelial cell activation    The change in morphology and behavior of an endothelial cell resulting from exposure to a cytokine, chemokine, cellular ligand, or soluble factor.
    GO:0043542    endothelial cell migration    The orderly movement of an endothelial cell into the extracellular matrix to form an endothelium.
    GO:0001837    epithelial to mesenchymal transition    A transition where an epithelial cell loses apical/basolateral polarity, severs intercellular adhesive junctions, degrades basement membrane components and becomes a migratory mesenchymal cell.
    GO:0043062    extracellular structure organization    A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of structures in the space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane, and also covers the host cell environment outside an intracellular parasite.
    GO:0008354    germ cell migration    The orderly movement of a cell specialized to produce haploid gametes through the embryo from its site of production to the place where the gonads will form.
    GO:0007507    heart development    The process whose specific outcome is the progression of the heart over time, from its formation to the mature structure. The heart is a hollow, muscular organ, which, by contracting rhythmically, keeps up the circulation of the blood.
    GO:0001701    in utero embryonic development    The process whose specific outcome is the progression of the embryo in the uterus over time, from formation of the zygote in the oviduct, to birth. An example of this process is found in Mus musculus.
    GO:0035556    intracellular signal transduction    The process in which a signal is passed on to downstream components within the cell, which become activated themselves to further propagate the signal and finally trigger a change in the function or state of the cell.
    GO:0001822    kidney development    The process whose specific outcome is the progression of the kidney over time, from its formation to the mature structure. The kidney is an organ that filters the blood and/or excretes the end products of body metabolism in the form of urine.
    GO:0002088    lens development in camera-type eye    The process whose specific outcome is the progression of the lens over time, from its formation to the mature structure. The lens is a transparent structure in the eye through which light is focused onto the retina. An example of this process is found in Mus musculus.
    GO:0008584    male gonad development    The process whose specific outcome is the progression of the male gonad over time, from its formation to the mature structure.
    GO:0048762    mesenchymal cell differentiation    The process in which a relatively unspecialized cell acquires specialized features of a mesenchymal cell. A mesenchymal cell is a loosely associated cell that is part of the connective tissue in an organism. Mesenchymal cells give rise to more mature connective tissue cell types.
    GO:0043066    negative regulation of apoptotic process    Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process.
    GO:0032331    negative regulation of chondrocyte differentiation    Any process that stops, prevents, or reduces the frequency, rate or extent of chondrocyte differentiation.
    GO:0001937    negative regulation of endothelial cell proliferation    Any process that stops, prevents, or reduces the rate or extent of endothelial cell proliferation.
    GO:2001237    negative regulation of extrinsic apoptotic signaling pathway    Any process that stops, prevents or reduces the frequency, rate or extent of extrinsic apoptotic signaling pathway.
    GO:0030512    negative regulation of transforming growth factor beta receptor signaling pathway    Any process that stops, prevents, or reduces the frequency, rate or extent of any TGF-beta receptor signaling pathway.
    GO:0048663    neuron fate commitment    The process in which the developmental fate of a cell becomes restricted such that it will develop into a neuron.
    GO:0060021    palate development    The biological process whose specific outcome is the progression of the palate from an initial condition to its mature state. This process begins with the formation of the structure and ends with the mature structure. The palate is the partition that separates the nasal and oral cavities.
    GO:0060017    parathyroid gland development    The process whose specific outcome is the progression of the parathyroid gland over time, from its formation to the mature structure. The parathyroid gland is an organ specialised for secretion of parathyroid hormone.
    GO:0060389    pathway-restricted SMAD protein phosphorylation    The process of introducing a phosphate group on to a pathway restricted SMAD protein. A pathway restricted SMAD protein is an effector protein that acts directly downstream of the transforming growth factor family receptor.
    GO:0018105    peptidyl-serine phosphorylation    The phosphorylation of peptidyl-serine to form peptidyl-O-phospho-L-serine.
    GO:0018107    peptidyl-threonine phosphorylation    The phosphorylation of peptidyl-threonine to form peptidyl-O-phospho-L-threonine.
    GO:0060037    pharyngeal system development    The process whose specific outcome is the progression of the pharyngeal system over time, from its formation to the mature structure. The pharyngeal system is a transient embryonic complex that is specific to vertebrates. It comprises the pharyngeal arches, bulges of tissues of mesoderm and neural crest derivation through which pass nerves and pharyngeal arch arteries. The arches are separated internally by pharyngeal pouches, evaginations of foregut endoderm, and externally by pharyngeal clefts, invaginations of surface ectoderm. The development of the system ends when the stucture it contributes to are forming: the thymus, thyroid, parathyroids, maxilla, mandible, aortic arch, cardiac outflow tract, external and middle ear.
    GO:0016310    phosphorylation    The process of introducing a phosphate group into a molecule, usually with the formation of a phosphoric ester, a phosphoric anhydride or a phosphoric amide.
    GO:0060391    positive regulation of SMAD protein import into nucleus    Any process that increases the rate, frequency or extent of SMAD protein import into the nucleus, i.e. the directed movement of a SMAD proteins from the cytoplasm into the nucleus. Pathway-restricted SMAD proteins and common-partner SMAD proteins are involved in the transforming growth factor beta receptor signaling pathways.
    GO:2001235    positive regulation of apoptotic signaling pathway    Any process that activates or increases the frequency, rate or extent of apoptotic signaling pathway.
    GO:0030307    positive regulation of cell growth    Any process that activates or increases the frequency, rate, extent or direction of cell growth.
    GO:0030335    positive regulation of cell migration    Any process that activates or increases the frequency, rate or extent of cell migration.
    GO:0008284    positive regulation of cell proliferation    Any process that activates or increases the rate or extent of cell proliferation.
    GO:0051272    positive regulation of cellular component movement    Any process that activates or increases the frequency, rate or extent of the movement of a cellular component.
    GO:0001938    positive regulation of endothelial cell proliferation    Any process that activates or increases the rate or extent of endothelial cell proliferation.
    GO:0051491    positive regulation of filopodium assembly    Any process that activates or increases the frequency, rate or extent of the assembly of a filopodium, a thin, stiff protrusion extended by the leading edge of a motile cell such as a crawling fibroblast or amoeba, or an axonal growth cone.
    GO:0010628    positive regulation of gene expression    Any process that increases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
    GO:0010862    positive regulation of pathway-restricted SMAD protein phosphorylation    Any process that increases the rate, frequency or extent of pathway-restricted SMAD protein phosphorylation. Pathway-restricted SMAD proteins and common-partner SMAD proteins are involved in the transforming growth factor beta receptor signaling pathways.
    GO:0051897    positive regulation of protein kinase B signaling    Any process that activates or increases the frequency, rate or extent of protein kinase B signaling, a series of reactions mediated by the intracellular serine/threonine kinase protein kinase B.
    GO:0045893    positive regulation of transcription, DNA-templated    Any process that activates or increases the frequency, rate or extent of cellular DNA-templated transcription.
    GO:0009791    post-embryonic development    The process whose specific outcome is the progression of the organism over time, from the completion of embryonic development to the mature structure. See embryonic development.
    GO:0006468    protein phosphorylation    The process of introducing a phosphate group on to a protein.
    GO:0010717    regulation of epithelial to mesenchymal transition    Any process that modulates the rate, frequency, or extent of epithelial to mesenchymal transition. Epithelial to mesenchymal transition where an epithelial cell loses apical/basolateral polarity, severs intercellular adhesive junctions, degrades basement membrane components and becomes a migratory mesenchymal cell.
    GO:0010468    regulation of gene expression    Any process that modulates the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
    GO:0040008    regulation of growth    Any process that modulates the frequency, rate or extent of the growth of all or part of an organism so that it occurs at its proper speed, either globally or in a specific part of the organism's development.
    GO:0043393    regulation of protein binding    Any process that modulates the frequency, rate or extent of protein binding.
    GO:0031396    regulation of protein ubiquitination    Any process that modulates the frequency, rate or extent of the addition of ubiquitin groups to a protein.
    GO:0006355    regulation of transcription, DNA-templated    Any process that modulates the frequency, rate or extent of cellular DNA-templated transcription.
    GO:0070723    response to cholesterol    Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cholesterol stimulus.
    GO:0007165    signal transduction    The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal (e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light), or for signal transduction in the absence of ligand, signal-withdrawal or the activity of a constitutively active receptor. Signal transduction ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell.
    GO:0023014    signal transduction by protein phosphorylation    A process in which the transfer of one or more phosphate groups to a substrate transmits a signal to the phosphorylated substrate.
    GO:0001501    skeletal system development    The process whose specific outcome is the progression of the skeleton over time, from its formation to the mature structure. The skeleton is the bony framework of the body in vertebrates (endoskeleton) or the hard outer envelope of insects (exoskeleton or dermoskeleton).
    GO:0048705    skeletal system morphogenesis    The process in which the anatomical structures of the skeleton are generated and organized.
    GO:0048538    thymus development    The process whose specific outcome is the progression of the thymus over time, from its formation to the mature structure. The thymus is a symmetric bi-lobed organ involved primarily in the differentiation of immature to mature T cells, with unique vascular, nervous, epithelial, and lymphoid cell components.
    GO:0007179    transforming growth factor beta receptor signaling pathway    A series of molecular signals initiated by the binding of an extracellular ligand to a transforming growth factor beta receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription.
    GO:0007178    transmembrane receptor protein serine/threonine kinase signaling pathway    A series of molecular signals initiated by the binding of an extracellular ligand to a receptor on the surface of the target cell where the receptor possesses serine/threonine kinase activity, and ending with regulation of a downstream cellular process, e.g. transcription.
    GO:0042060    wound healing    The series of events that restore integrity to a damaged tissue, following an injury.
cellular component
    GO:0005923    bicellular tight junction    An occluding cell-cell junction that is composed of a branching network of sealing strands that completely encircles the apical end of each cell in an epithelial sheet; the outer leaflets of the two interacting plasma membranes are seen to be tightly apposed where sealing strands are present. Each sealing strand is composed of a long row of transmembrane adhesion proteins embedded in each of the two interacting plasma membranes.
    GO:0005623    cell    The basic structural and functional unit of all organisms. Includes the plasma membrane and any external encapsulating structures such as the cell wall and cell envelope.
    GO:0030054    cell junction    A cellular component that forms a specialized region of connection between two or more cells or between a cell and the extracellular matrix. At a cell junction, anchoring proteins extend through the plasma membrane to link cytoskeletal proteins in one cell to cytoskeletal proteins in neighboring cells or to proteins in the extracellular matrix.
    GO:0009986    cell surface    The external part of the cell wall and/or plasma membrane.
    GO:0005768    endosome    A vacuole to which materials ingested by endocytosis are delivered.
    GO:0016021    integral component of membrane    The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
    GO:0005622    intracellular    The living contents of a cell; the matter contained within (but not including) the plasma membrane, usually taken to exclude large vacuoles and masses of secretory or ingested material. In eukaryotes it includes the nucleus and cytoplasm.
    GO:0016020    membrane    A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it.
    GO:0045121    membrane raft    Any of the small (10-200 nm), heterogeneous, highly dynamic, sterol- and sphingolipid-enriched membrane domains that compartmentalize cellular processes. Small rafts can sometimes be stabilized to form larger platforms through protein-protein and protein-lipid interactions.
    GO:0005886    plasma membrane    The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
    GO:0043235    receptor complex    Any protein complex that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function.
    GO:0070022    transforming growth factor beta receptor complex    A homodimeric receptor complex that consists of two TGF-beta receptor monomers.

 Visualization

(-) Interactive Views

Asymmetric Unit
  Complete Structure
    Jena3D(integrated viewing of ligand, site, SAP, PROSITE, SCOP information)
    WebMol | AstexViewer[tm]@PDBe
(Java Applets, require no local installation except for Java; loading may be slow)
    STRAP
(Java WebStart application, automatic local installation, requires Java; full application with system access!)
    RasMol
(require local installation)
    Molscript (VRML)
(requires installation of a VRML viewer; select preferred view via VRML and generate a mono or stereo PDF format file)
 
  Ligands, Modified Residues, Ions
    55F  [ RasMol | Jena3D ]  +environment [ RasMol | Jena3D ]
    PO4  [ RasMol | Jena3D ]  +environment [ RasMol | Jena3D ]
 
  Sites
    AC1  [ RasMol ]  +environment [ RasMol ]
    AC2  [ RasMol ]  +environment [ RasMol ]
    AC3  [ RasMol ]  +environment [ RasMol ]
    AC4  [ RasMol ]  +environment [ RasMol ]
    AC5  [ RasMol ]  +environment [ RasMol ]
    AC6  [ RasMol ]  +environment [ RasMol ]
    AC7  [ RasMol ]  +environment [ RasMol ]
    AC8  [ RasMol ]  +environment [ RasMol ]
    AC9  [ RasMol ]  +environment [ RasMol ]
    BC1  [ RasMol ]  +environment [ RasMol ]
    BC2  [ RasMol ]  +environment [ RasMol ]
    BC3  [ RasMol ]  +environment [ RasMol ]
    BC4  [ RasMol ]  +environment [ RasMol ]
    BC5  [ RasMol ]  +environment [ RasMol ]
    BC6  [ RasMol ]  +environment [ RasMol ]
    BC7  [ RasMol ]  +environment [ RasMol ]
    BC8  [ RasMol ]  +environment [ RasMol ]
    BC9  [ RasMol ]  +environment [ RasMol ]
 
  Cis Peptide Bonds
(no "Cis Peptide Bonds" information available for 3faa)
 
Biological Units
  Complete Structure
    Biological Unit 1  [ Jena3D ]
    Biological Unit 2  [ Jena3D ]
    Biological Unit 3  [ Jena3D ]
    Biological Unit 4  [ Jena3D ]
    Biological Unit 5  [ Jena3D ]

(-) Still Images

Jmol
  protein: cartoon or spacefill or dots and stick; nucleic acid: cartoon and stick; ligands: spacefill; active site: stick
Molscript
  protein, nucleic acid: cartoon; ligands: spacefill; active site: ball and stick

 Databases and Analysis Tools

(-) Databases

Access by PDB/NDB ID
  3faa
    Family and Domain InformationProDom | SYSTERS
    General Structural InformationGlycoscienceDB | MMDB | NDB | OCA | PDB | PDBe | PDBj | PDBsum | PDBWiki | PQS | PROTEOPEDIA
    Orientation in MembranesOPM
    Protein SurfaceSURFACE
    Secondary StructureDSSP (structure derived) | HSSP (homology derived)
    Structural GenomicsGeneCensus
    Structural NeighboursCE | VAST
    Structure ClassificationCATH | Dali | SCOP
    Validation and Original DataBMRB Data View | BMRB Restraints Grid | EDS | PROCHECK | RECOORD | WHAT_CHECK
 
Access by UniProt ID/Accession number
  TGFR1_HUMAN | P36897
    Comparative Protein Structure ModelsModBase
    Genomic InformationEnsembl
    Protein-protein InteractionDIP
    Sequence, Family and Domain InformationInterPro | Pfam | SMART | UniProtKB/SwissProt
 
Access by Enzyme Classificator   (EC Number)
  2.7.11.30
    General Enzyme InformationBRENDA | EC-PDB | Enzyme | IntEnz
    PathwayKEGG | MetaCyc
 
Access by Disease Identifier   (MIM ID)
  609192
    Disease InformationOMIM
 
Access by GenAge ID
  (no 'GenAge ID' available)
    Age Related InformationGenAge

(-) Analysis Tools

Access by PDB/NDB ID
    Domain InformationXDom
    Interatomic Contacts of Structural UnitsCSU
    Ligand-protein ContactsLPC
    Protein CavitiescastP
    Sequence and Secondary StructurePDBCartoon
    Structure AlignmentSTRAP(Java WebStart application, automatic local installation, requires Java; full application with system access!)
    Structure and Sequence BrowserSTING
 
Access by UniProt ID/Accession number
  TGFR1_HUMAN | P36897
    Protein Disorder PredictionDisEMBL | FoldIndex | GLOBPLOT (for more information see DisProt)

 Related Entries

(-) Entries Sharing at Least One Protein Chain (UniProt ID)

UniProtKB/Swiss-Prot
        TGFR1_HUMAN | P368971b6c 1ias 1py5 1rw8 1tbi 1vjy 2l5s 2pjy 2wot 2wou 2x7o 3gxl 3hmm 3kcf 3kfd 3tzm 4x0m 4x2f 4x2g 4x2j 4x2k 4x2n 5e8s 5e8t 5e8u 5e8w 5e8x 5e8z 5e90 5fri 5usq

(-) Related Entries Specified in the PDB File

(no "Related Entries Specified in the PDB File" available for 3FAA)